Additionally, although outside the primary scope of this study, 139 samples (4.9% of the unique-patient 2826 samples tested exclusively for B19V serology) were identified during the same period with laboratory-confirmed B19V infection based on the presence of B19V-specific IgM antibodies, indicative of recent infection. Here, CD40LG is linked to infection.